Recombinant Anti-tumor and Anti-virus Protein for Injection in Treatment of Metastatic Colorectal Cancer
Status:
Completed
Trial end date:
2014-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the efficacy and safety of recombinant anti-tumor
and anti-virus protein for injection in treating patients with metastatic colorectal cancer
after failure of second-line and more than second-line treatment.
Phase:
Phase 2
Details
Lead Sponsor:
The Affiliated Hospital of the Chinese Academy of Military Medical Sciences